Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BP101 in Female HSDD
NCT03463707Phase 3Completed
- Start
- Mar 2018
- Primary completion
- Nov 2018
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of BP101 in hypoactive sexual desire disorder (HSDD). Started Mar 2018; status: completed.
02
Drugs
BP101
03
Conditions
hypoactive sexual desire disorder (HSDD)
Beyond the preview
Go deeper on NCT03463707.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03463707.